Ulvi Murat Yuksel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ulvi Murat Yuksel has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Sevim Turanli
Department of General Surgery, Ankara Oncology Training and Research Hospital, Ankara, Turkey
2 shared publicationsUgur Berberoglu
Department of General Surgery, Ankara Oncology Training and Research Hospital, Ankara, Turkey
2 shared publicationsAli Ugur Berberoglu
Department of General Surgery, Ankara Oncology Education and Research Hospital, Ankara, Turkey
1 shared publicationGulay Dilek
Department of Pathology, Oncology Training and Research Hospital, Ankara - Turkey
1 shared publicationKaptan Gulben
Department of General Surgery, Ankara Oncology Education and Research Hospital, Ankara, Turkey
1 shared publicationLutfi Dogan
Department of Surgery, Oncology Training and Research Hospital, Ankara - Turkey
1 shared publication
Latest Publications
- 1 January 2019
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 15 (3) , 681-685
The prognostic factors for clinical N1b patients in thyroid papillary carcinoma
Background: The aim of this study is to determine the prognostic factors which affect both disease-free survival (DFS) and overall survival (OS) in thyroid papillary carcinoma with clinical lateral lymph node metastasis. Methods: One hundred and three papillary thyroid carcinomas diagnosed in adult patients received therapeutic lateral neck dissection between December 1989 and June 2010 were analyzed retrospectively. All of the patients were classified as American Thyroid Association (ATA) intermediate risk category. Age, gender, tumor stage and size, multicentricity and bilaterality, vascular invasion and extrathyroidal invasion, ipsilateral/contralateral lymph node involvement, lymph node ratio, extranodal tumor extension, and development of recurrence were the factors which might affect disease-free and OS. Univariate and multivariate analyses were performed. ROC analysis was used to find the cutoff value for lymph node ratio. Results: One hundred and three patients were followed median 101 months. Locoregional or systemic recurrence developed in 20 patients (19.4%) while 7 patients (6.8%) had persistent disease. In multivariate analysis, lymph node ratio (P = 0.003, relative risk [RR] 5.4, 95% confident interval [CI] 1.7–16.5) and contralateral lymph node involvement (P = 0.02, RR 4.9, 95% CI 1.3–18.5) were the independent factors affecting DFS where contralateral lymph node involvement (P = 0.009, RR 44.4, 95% CI 2.5–765.2) was the only factor which affected OS. Conclusions: Lymph node ratio and contralateral metastasis affect DFS while contralateral metastases only affect OS in patients with N1b thyroid papillary carcinoma.
- 1 January 2019
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 15 (3) , 681-685
The prognostic factors for clinical N1b patients in thyroid papillary carcinoma
Background: The aim of this study is to determine the prognostic factors which affect both disease-free survival (DFS) and overall survival (OS) in thyroid papillary carcinoma with clinical lateral lymph node metastasis. Methods: One hundred and three papillary thyroid carcinomas diagnosed in adult patients received therapeutic lateral neck dissection between December 1989 and June 2010 were analyzed retrospectively. All of the patients were classified as American Thyroid Association (ATA) intermediate risk category. Age, gender, tumor stage and size, multicentricity and bilaterality, vascular invasion and extrathyroidal invasion, ipsilateral/contralateral lymph node involvement, lymph node ratio, extranodal tumor extension, and development of recurrence were the factors which might affect disease-free and OS. Univariate and multivariate analyses were performed. ROC analysis was used to find the cutoff value for lymph node ratio. Results: One hundred and three patients were followed median 101 months. Locoregional or systemic recurrence developed in 20 patients (19.4%) while 7 patients (6.8%) had persistent disease. In multivariate analysis, lymph node ratio (P = 0.003, relative risk [RR] 5.4, 95% confident interval [CI] 1.7–16.5) and contralateral lymph node involvement (P = 0.02, RR 4.9, 95% CI 1.3–18.5) were the independent factors affecting DFS where contralateral lymph node involvement (P = 0.009, RR 44.4, 95% CI 2.5–765.2) was the only factor which affected OS. Conclusions: Lymph node ratio and contralateral metastasis affect DFS while contralateral metastases only affect OS in patients with N1b thyroid papillary carcinoma.
- 13 January 2017
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 80 (4) , 318-321
Management of Incidentally Diagnosed Splenic Masses
- 13 January 2017
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 80 (4) , 318-321
Management of Incidentally Diagnosed Splenic Masses
- 16 March 2015
- Published by SAGE Publications in Tumori Journal
- Vol. 101 (2) , 194-198
The Relationship between CSE1L Expression and Axillary Lymph Node Metastasis in Breast Cancer
Aim: CSE1L is the human homologue to the yeast gene CSE1 and CSE1L is a gene related to cancer progression. Thus, CSE1L may regulate the invasion and metastasis of breast cancer. The aim of this study is to show the relationship between CSE1L and axillary lymph node metastasis. Methods: Sixty-six breast cancer patients were evaluated according to patient and tumor characteristics. Immunohistochemistry was carried out on formalin-fixed, paraffin-embedded archival breast tumor tissues. The results of CSE1L staining were analyzed according to the percentage of immunoreactive cells. Results: There were 29 patients without axillary lymph node metastasis and 37 patients with nodal metastasis. The mean age of the patients was 50.6 ± 11.3 years. Age, tumor size, nuclear grade and hormone receptor status were similar in the axillary lymph node positive and negative groups. There was a statistically significant relationship between cytoplasmic CSE1L expression and axillary lymph node metastasis. However, nuclear CSE1L expression did not have any effect on axillary lymph node metastasis. Conclusions: Cytoplasmic CSE1L overexpression may be a valuable tool for prognosis of breast cancer in future.
- 16 March 2015
- Published by SAGE Publications in Tumori Journal
- Vol. 101 (2) , 194-198
The Relationship between CSE1L Expression and Axillary Lymph Node Metastasis in Breast Cancer
Aim: CSE1L is the human homologue to the yeast gene CSE1 and CSE1L is a gene related to cancer progression. Thus, CSE1L may regulate the invasion and metastasis of breast cancer. The aim of this study is to show the relationship between CSE1L and axillary lymph node metastasis. Methods: Sixty-six breast cancer patients were evaluated according to patient and tumor characteristics. Immunohistochemistry was carried out on formalin-fixed, paraffin-embedded archival breast tumor tissues. The results of CSE1L staining were analyzed according to the percentage of immunoreactive cells. Results: There were 29 patients without axillary lymph node metastasis and 37 patients with nodal metastasis. The mean age of the patients was 50.6 ± 11.3 years. Age, tumor size, nuclear grade and hormone receptor status were similar in the axillary lymph node positive and negative groups. There was a statistically significant relationship between cytoplasmic CSE1L expression and axillary lymph node metastasis. However, nuclear CSE1L expression did not have any effect on axillary lymph node metastasis. Conclusions: Cytoplasmic CSE1L overexpression may be a valuable tool for prognosis of breast cancer in future.